Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century.
about
A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysisRapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase methodUnderstanding pharmacokinetics to improve tuberculosis treatment outcome.Genes required for intrinsic multidrug resistance in Mycobacterium avium.Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamideAnalysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence communityLuciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons.A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance.Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent.Worldwide emergence of extensively drug-resistant tuberculosis.Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis.Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia.Electrochemical Genosensing of Circulating Biomarkers.Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from IndiaSusceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis.Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing SystemComparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis.
P2860
Q24812788-B55F1E62-8591-4B7E-9AB8-D37AB8EEC64BQ28477917-3E92D97E-5D87-4C37-8934-D31EAA63AD32Q30411703-5931291C-3F05-41BA-8D02-C27C1E77F547Q33206220-984226D9-10B0-4197-B5CA-26B011749EB8Q33270256-52116A63-4978-4FB1-9B0D-F0142F79319BQ33966438-D4E5AF82-DE3C-4C80-B3FF-52A4C2DB0F31Q33971262-C3E5DE30-EF57-4DC3-8D0D-501FAFD5D274Q33973893-B17511E9-B3EC-4F2D-BCC3-2B4BEF2A60FDQ33974090-9E014148-0969-422D-871E-68A9CE95A438Q34707937-DDFDF014-51F6-4176-BCED-ECAD8D7EF077Q34974987-1DA66161-74DB-4DE8-A1F3-A0DF98A09241Q35566384-6E68CABC-5E5F-40B8-B765-39D12B490857Q36853870-7E995B42-1536-4DF5-AA89-3977FF7D0877Q36933148-3ECA6394-518A-4B31-A780-A2817994A4B8Q37191625-91239651-4DF7-459F-805C-290F2DB59FA4Q37302822-1D7E4E3B-4E2A-4F3F-94F4-343E7671374BQ37508502-5157E4E6-2BF1-41B2-96E9-5F9B639BB713Q37702443-2679058A-610A-48D5-96B3-92F60B2AFF55Q38728726-EE910703-2762-4E17-A56E-C4148A0000DDQ39094119-093EBAD7-AC4E-4EC6-91F7-9C9787732A4DQ39335226-093DFD24-F672-4593-B4A9-329CA44B160CQ39465866-EA1A0A89-9BAE-4864-90EB-1771C80D9763Q39735527-A7FCCDCE-DB87-402D-8F08-F3318A3AF3ACQ40727240-066D81F6-021D-442A-BEC8-6DFD33771857Q47139099-3F315389-3E1C-450E-A798-CE2E06941924Q55227253-F6B1BFA4-A06D-42C7-898D-8CDCCF009F92
P2860
Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Drug susceptibility testing of ...... em at the turn of the century.
@ast
Drug susceptibility testing of ...... em at the turn of the century.
@en
type
label
Drug susceptibility testing of ...... em at the turn of the century.
@ast
Drug susceptibility testing of ...... em at the turn of the century.
@en
prefLabel
Drug susceptibility testing of ...... em at the turn of the century.
@ast
Drug susceptibility testing of ...... em at the turn of the century.
@en
P1476
Drug susceptibility testing of ...... em at the turn of the century.
@en
P2093
Cangelosi GA
Heifets LB
P304
P577
1999-07-01T00:00:00Z